Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Feasibility Study for Repurposing RET Inhibitors [EARLY_Phase 1]

View source ↗

Summary

Feasibility study in early-phase 1 to repurpose RET inhibitors for cachexia-anorexia syndrome; trial status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RET inhibitors

Snippet

Sponsor: University of Oklahoma | Conditions: Cachexia-Anorexia Syndrome | EARLY_Phase 1 | Status: NOT_YET_RECRUITING